Back to Search
Start Over
The Ribonuclease ZC3H12A is required for self-inflicted DNA breaks after DNA damage in small cell lung cancer cells.
- Source :
-
Cellular oncology (Dordrecht, Netherlands) [Cell Oncol (Dordr)] 2024 Aug; Vol. 47 (4), pp. 1497-1502. Date of Electronic Publication: 2024 Mar 18. - Publication Year :
- 2024
-
Abstract
- Radiotherapy is the first line treatment for small cell lung cancer (SCLC); However, radio-resistance accompanies with the treatment and hampers the prognosis for SCLC patients. The underlying mechanisms remains elusive. Here we discovered that self-inflicted DNA breaks exist in SCLC cells after radiation. Moreover, using nuclease siRNA screening combined with high-content ArrayScan™ cell analyzer, we identified that Ribonuclease ZC3H12A is required for the self-inflicted DNA breaks after radiation and for SCLC cell survival after DNA damage. ZC3H12A expression was increased in response to DNA damage and when ZC3H12A was knocked down, the DNA repair ability of the cells was impaired, as evidenced by decreased expression of the DNA damage repair protein BRCA1, and increased γH2AX at DNA damage sites. Colony formation assay demonstrates that ZC3H12A knocked down sensitized small cell lung cancer radiotherapy. Therefore, the Ribonuclease ZC3H12A regulates endogenous secondary breaks in small cell lung cancer and affects DNA damage repair. ZC3H12A may act as an important radiotherapy target in small cell lung cancer.<br /> (© 2024. Springer Nature Switzerland AG.)
- Subjects :
- Humans
Cell Line, Tumor
Cell Survival
Gene Knockdown Techniques
RNA, Small Interfering metabolism
Histones metabolism
Transcription Factors
Lung Neoplasms genetics
Lung Neoplasms pathology
Lung Neoplasms metabolism
Small Cell Lung Carcinoma genetics
Small Cell Lung Carcinoma pathology
Small Cell Lung Carcinoma metabolism
Ribonucleases metabolism
Ribonucleases genetics
DNA Repair
DNA Damage
Subjects
Details
- Language :
- English
- ISSN :
- 2211-3436
- Volume :
- 47
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Cellular oncology (Dordrecht, Netherlands)
- Publication Type :
- Editorial & Opinion
- Accession number :
- 38498096
- Full Text :
- https://doi.org/10.1007/s13402-024-00941-x